We are live on
!
Find out more
AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
38 hedge funds and large institutions have $8.81M invested in Agile Therapeutics in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
17% less funds holding
Funds holding: 46 → 38 (-8)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
86% less capital invested
Capital invested by funds: $63.4M → $8.81M (-$54.6M)
Holders
38
Holders Change
-8
Holders Change %
-17.39%
% of All Funds
0.87%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
6
Increased
9
Reduced
9
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$600K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$189K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$133K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$87.7K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$87.7K |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$4.81M |
| 2 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$4.66M |
| 3 |
AC
Aisling Capital
New York
|
-$3.35M |
| 4 |
JGC
J. Goldman & Co
New York
|
-$993K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$666K |
